Ampio Pharmaceuticals, Inc. (AMPE) Financials

$0.00

south_east
-$0 (0%)
Day's range
$0
Day's range
$0.02
$40M$40M$20M$20M$0$0-$20M-$20M-$40M-$40M-$60M-$60MEarning201720172018201820192019202020202021202120222022202320235%5%4%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

AMPE Income statement / Annual

Last year (2023), Ampio Pharmaceuticals, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, Ampio Pharmaceuticals, Inc.'s net income was -$8.63 M. See Ampio Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.16 M $76,787.00
Cost of Revenue $250,000.00 $2.08 M $1.09 M $1.18 M $1.27 M $523,000.00 $568,000.00 $950,000.00 $369,309.00 $2.24 M
Gross Profit -$250,000.00 -$2.08 M -$1.09 M -$1.18 M -$1.27 M -$523,000.00 -$568,000.00 -$950,000.00 $793,153.00 -$2.16 M
Gross Profit Ratio 0 0 0 0 0 0 0 0 0.68 -28.18
Research and Development Expenses $2.32 M $8.92 M $11.90 M $9.17 M $12.62 M $6.83 M $10.42 M $10.55 M $18.96 M $26.92 M
General & Administrative Expenses $7.08 M $11.47 M $8.67 M $6.65 M $5.90 M $4.36 M $5.14 M $6.54 M $15.14 M $12.23 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $7.08 M $11.47 M $8.67 M $6.65 M $5.90 M $4.36 M $5.14 M $6.54 M $15.14 M $12.23 M
Other Expenses $0.00 $1.94 M $0.00 $12,000.00 $56,000.00 $0.00 $323,554.00 $143,802.00 $0.00 $0.00
Operating Expenses $9.27 M $20.38 M $20.57 M $15.83 M $18.58 M $11.18 M $15.56 M $17.08 M $34.10 M $39.15 M
Cost And Expenses $9.52 M $20.38 M $20.57 M $15.83 M $18.58 M $11.18 M $15.56 M $17.08 M $34.46 M $39.15 M
Interest Income $348,000.00 $220,000.00 $4,000.00 $12,000.00 $77,000.00 $5,000.00 $3,086.00 $23,479.00 $59,853.00 $22,263.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $77,000.00 $0.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $127,000.00 $2.08 M $1.09 M $1.18 M $1.27 M $1.28 M $1.21 M $1.21 M $1.14 M $439,098.00
EBITDA $0.00 -$18.30 M $0.00 $0.00 -$17.30 M $35.26 M -$14.46 M -$14.81 M -$23.34 M $0.00
EBITDA Ratio 0 0 0 0 0 0 0 0 -27.6 -503.11
Operating Income Ratio 0 0 0 0 0 0 0 0 -28.65 -508.83
Total Other Income/Expenses Net $886,000.00 $4.05 M $3.50 M -$60,000.00 $4.95 M $45.17 M -$36.22 M -$2.08 M -$412,071.00 -$7.60 M
Income Before Tax -$8.63 M -$16.34 M -$17.08 M -$15.89 M -$13.63 M $33.99 M -$51.89 M -$19.16 M -$33.71 M -$39.05 M
Income Before Tax Ratio 0 0 0 0 0 0 0 0 -29 -508.54
Income Tax Expense $0.00 -$7.87 M -$4.59 M $604,000.00 -$4.95 M $45.17 M $36.33 M $1.04 M -$1.29 M -$923,523.00
Net Income -$8.63 M -$8.47 M -$12.49 M -$16.50 M -$8.68 M $33.99 M -$51.89 M -$19.16 M -$32.01 M -$38.13 M
Net Income Ratio 0 0 0 0 0 0 0 0 -27.54 -496.51
EPS -10.67 -11.24 -18.79 -28.63 -18.32 92.1 -239.13 -107.06 -184.7 -227.72
EPS Diluted -10.66 -11.24 -18.59 -27.71 -18.32 91.9 -238.41 -106.91 -184.7 -227.72
Weighted Average Shares Out $809,000.00 $753,615.00 $664,330.00 $576,155.00 $474,026.00 $369,000.00 $217,000.00 $179,000.00 $173,306.00 $167,421.00
Weighted Average Shares Out Diluted $810,113.00 $753,619.00 $671,493.00 $595,407.00 $474,026.00 $369,805.00 $217,658.00 $179,244.00 $173,306.00 $167,421.00
Link